当前位置:首页 - 行情中心 - 亨迪药业(301211) - 财务分析 - 现金流量表

亨迪药业

(301211)

  

流通市值:52.12亿  总市值:52.12亿
流通股本:4.18亿   总股本:4.18亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金288,873,181.83191,151,557.6484,963,878.41394,247,974.5
  收到的税费返还5,229,831.994,374,044.841,875,163.6717,588,808.78
  收到其他与经营活动有关的现金19,827,594.0313,668,096.5920,232,610.3748,716,219.93
  经营活动现金流入小计313,930,607.85209,193,699.07107,071,652.45460,553,003.21
  购买商品、接受劳务支付的现金139,589,751.4197,977,511.0142,824,953.22179,182,170.67
  支付给职工以及为职工支付的现金81,275,619.3856,859,276.7129,577,405.77108,147,173.34
  支付的各项税费15,247,522.328,633,736.764,932,850.3226,377,453.52
  支付其他与经营活动有关的现金58,947,376.737,321,880.3623,679,461.3850,772,962.79
  经营活动现金流出小计295,060,269.81200,792,404.84101,014,670.69364,479,760.32
  经营活动产生的现金流量净额18,870,338.048,401,294.236,056,981.7696,073,242.89
二、投资活动产生的现金流量:
  收回投资收到的现金174,284,491.68144,284,491.6820,000,00094,770,178.15
  取得投资收益收到的现金4,720,661.413,617,244.742,146,333.344,448,988.52
  处置固定资产、无形资产和其他长期资产收回的现金净额36,170.6711,870.671,74994,556.5
  投资活动现金流入小计179,041,323.76147,913,607.0922,148,082.3499,313,723.17
  购建固定资产、无形资产和其他长期资产支付的现金42,293,706.4525,658,235.0326,763,976.34164,429,506.28
  投资支付的现金90,000,00070,000,00050,000,0001,044,345,991.68
  投资活动现金流出小计132,293,706.4595,658,235.0376,763,976.341,208,775,497.96
  投资活动产生的现金流量净额46,747,617.3152,255,372.06-54,615,894-1,109,461,774.79
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金72,000,00072,000,000-138,240,000
  支付其他与筹资活动有关的现金815,730.94815,730.94-1,631,461.88
  筹资活动现金流出平衡项目00-0
  筹资活动现金流出小计72,815,730.9472,815,730.94-139,871,461.88
  筹资活动产生的现金流量净额平衡项目00-0
  筹资活动产生的现金流量净额-72,815,730.94-72,815,730.94--139,871,461.88
四、汇率变动对现金及现金等价物的影响-120,532.69388,707.74149,007.982,073,270.73
五、现金及现金等价物净增加额-7,318,308.28-11,770,356.91-48,409,904.26-1,151,186,723.05
  加:期初现金及现金等价物余额543,139,791.63543,039,791.63543,139,791.631,694,226,514.68
  期末现金及现金等价物余额535,821,483.35531,269,434.72494,729,887.37543,039,791.63
补充资料:
  净利润-18,547,082.58-91,547,379.78
  资产减值准备-2,029,344.38--
  固定资产和投资性房地产折旧-20,787,354.9-21,844,944.52
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-20,787,354.9-21,844,944.52
  无形资产摊销-1,056,518.82-2,200,491.57
  长期待摊费用摊销-142,846.68-285,693.36
  处置固定资产、无形资产和其他长期资产的损失--11,870.67--
  固定资产报废损失-18,897.11-108,220.77
  公允价值变动损失--10,571,513.92--14,579,944.46
  财务费用-64,974.01--1,760,998.14
  投资损失--4,282,814.18--4,448,988.52
  递延所得税-1,449,458.22-1,628,227.31
  其中:递延所得税资产减少--139,856.93-201,540.78
    递延所得税负债增加-1,589,315.15-1,426,686.53
  存货的减少-19,925,750.84-35,953,642.67
  经营性应收项目的减少-4,140,523.69-1,273,604.1
  经营性应付项目的增加--46,321,665.56--39,440,579.15
  现金的期末余额-531,269,434.72-543,039,791.63
  减:现金的期初余额-543,039,791.63-1,694,226,514.68
  现金及现金等价物的净增加额--11,770,356.91--1,151,186,723.05
公告日期2025-10-282025-08-012025-04-282025-04-24
审计意见(境内)标准无保留意见标准无保留意见
TOP↑